Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-31true02023-03-01trueNo description of principal activity0truefalse 13181402 2023-03-01 2023-12-31 13181402 2022-03-01 2023-02-28 13181402 2023-12-31 13181402 2023-02-28 13181402 c:Director1 2023-03-01 2023-12-31 13181402 d:CurrentFinancialInstruments 2023-12-31 13181402 d:CurrentFinancialInstruments 2023-02-28 13181402 d:ShareCapital 2023-12-31 13181402 d:ShareCapital 2023-02-28 13181402 c:EntityHasNeverTraded 2023-03-01 2023-12-31 13181402 c:FRS102 2023-03-01 2023-12-31 13181402 c:AuditExempt-NoAccountantsReport 2023-03-01 2023-12-31 13181402 c:FullAccounts 2023-03-01 2023-12-31 13181402 c:PrivateLimitedCompanyLtd 2023-03-01 2023-12-31 13181402 e:PoundSterling 2023-03-01 2023-12-31 iso4217:GBP xbrli:pure

Registered number: 13181402










RESONANT MANAGEMENT LIMITED (FORMERLY WARNER MEDICAL LIMITED)








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 DECEMBER 2023

 
RESONANT MANAGEMENT LIMITED
REGISTERED NUMBER: 13181402

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2023

31 December
28 February
2023
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 3 
1
1

Net assets
  
1
1


Capital and reserves
  

Called up share capital 
  
1
1

  
1
1


For the period ended 31 December 2023 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 






DJ Youds
Director

Date: 14 September 2024

The notes on page 2 form part of these financial statements.

Page 1

 
RESONANT MANAGEMENT LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

1.


General information

Resonant Management Limited (13181402) is a private company limited by shares and incorporated in England & Wales. Its registered office is Wey Court West, Union Road, Farnham, Surrey, GU9 7PT.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

 
2.2

Debtors

Short-term debtors are measured at transaction price, less any impairment.


3.


Debtors

31 December
28 February
2023
2023
£
£


Called up share capital not paid
1
1


Page 2